...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Cross-Talk between Gut Microbiota and the Heart: A New Target for the Herbal Medicine Treatment of Heart Failure?
【24h】

Cross-Talk between Gut Microbiota and the Heart: A New Target for the Herbal Medicine Treatment of Heart Failure?

机译:肠道微生物群和心脏之间的跨谈:一种新的草药治疗心力衰竭的目标?

获取原文
           

摘要

Heart failure (HF) is the severe and terminal stage of various heart diseases. A growing number of studies have suggested the potential clinical significance of gut microbiota in the pathophysiology of HF. Herbal medicine (HM) plays a role in rebalancing the composition of gut microbiota and is widely used in the prevention and treatment of HF. There are many similarities between intestinal microecology and the traditional Chinese medicine (TCM) theory, such as the holistic concept and the theory of the “heart’s connection with the small intestine.” These similarities provide a theoretical basis for HM to prevent and treat diseases by regulating the intestinal flora and its metabolites. In this work, the cross-talk between gut microbiota and the heart is reviewed, and the relationship between TCM and gut microbiota is discussed. Based on the current literature and research, we hypothesize that the cross-talk between gut microbiota and the heart may offer a new therapeutic target for HF intervention.
机译:心力衰竭(HF)是各种心脏病的严重和末期阶段。越来越多的研究表明肠道微生物在HF病理生理学中的潜在临床意义。草药(HM)在重新平衡肠道微生物的组成中起着作用,并且广泛用于预防和治疗HF。肠道微生质和中医(中医)理论之间存在许多相似之处,例如整体概念和“心脏与小肠的关系”。这些相似之处为HM提供了通过调节肠道菌群及其代谢物来预防和治疗疾病的理论依据。在这项工作中,审查了肠道微生物群和心脏之间的串扰,讨论了TCM和肠道微生物的关系。基于目前的文献和研究,我们假设肠道微生物群和心脏之间的串扰可以为HF干预提供新的治疗目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号